COEP
Coeptis Therapeutics·NASDAQ
--
--(--)
--
--(--)
0.78 / 10
Underperform
Fundamental assessment is challenging with a score of 0.8/10. Key issues include negative asset-to-market value and revenue-to-market value ratios, low net profit margin, and poor current assets turnover. Only the net profit attributable to shareholders ratio shows a relatively positive signal at 97.04%, but it is insufficient to offset other weaknesses. Historical back-tests for each factor reveal consistently negative one-month returns, reinforcing the underperform stance.
Analysis Checks(1/10)
Revenue-MV
Value-3.96
Score1/3
Weight1.48%
1M Return-0.58%
Value-3.96
Score1/3
Weight1.48%
1M Return-0.58%
Total operating revenue (YoY growth rate %)
Value78.47
Score0/3
Weight13.74%
1M Return-6.59%
Value78.47
Score0/3
Weight13.74%
1M Return-6.59%
Net income-Revenue
Value-0.17
Score1/3
Weight1.89%
1M Return-0.69%
Value-0.17
Score1/3
Weight1.89%
1M Return-0.69%
Current assets turnover ratio
Value0.14
Score0/3
Weight12.88%
1M Return-7.31%
Value0.14
Score0/3
Weight12.88%
1M Return-7.31%
Asset-MV
Value-0.50
Score1/3
Weight1.57%
1M Return-0.51%
Value-0.50
Score1/3
Weight1.57%
1M Return-0.51%
Net profit attributable to parent company shareholders / Net profit (%)
Value97.04
Score2/3
Weight4.23%
1M Return-1.63%
Value97.04
Score2/3
Weight4.23%
1M Return-1.63%
Net cash flow from operating activities / Operating revenue (%)
Value-1380.28
Score0/3
Weight15.86%
1M Return-7.70%
Value-1380.28
Score0/3
Weight15.86%
1M Return-7.70%
Net profit margin (%)
Value-2126.62
Score0/3
Weight16.52%
1M Return-8.03%
Value-2126.62
Score0/3
Weight16.52%
1M Return-8.03%
EBIT / Total operating revenue (%)
Value-2086.32
Score0/3
Weight15.63%
1M Return-7.44%
Value-2086.32
Score0/3
Weight15.63%
1M Return-7.44%
Net profit / Total operating revenue (%)
Value-2126.62
Score0/3
Weight16.21%
1M Return-7.85%
Value-2126.62
Score0/3
Weight16.21%
1M Return-7.85%
Revenue-MV
Value-3.96
Score1/3
Weight1.48%
1M Return-0.58%
Value-3.96
Score1/3
Weight1.48%
1M Return-0.58%
Net profit attributable to parent company shareholders / Net profit (%)
Value97.04
Score2/3
Weight4.23%
1M Return-1.63%
Value97.04
Score2/3
Weight4.23%
1M Return-1.63%
Total operating revenue (YoY growth rate %)
Value78.47
Score0/3
Weight13.74%
1M Return-6.59%
Value78.47
Score0/3
Weight13.74%
1M Return-6.59%
Net cash flow from operating activities / Operating revenue (%)
Value-1380.28
Score0/3
Weight15.86%
1M Return-7.70%
Value-1380.28
Score0/3
Weight15.86%
1M Return-7.70%
Net income-Revenue
Value-0.17
Score1/3
Weight1.89%
1M Return-0.69%
Value-0.17
Score1/3
Weight1.89%
1M Return-0.69%
Net profit margin (%)
Value-2126.62
Score0/3
Weight16.52%
1M Return-8.03%
Value-2126.62
Score0/3
Weight16.52%
1M Return-8.03%
Current assets turnover ratio
Value0.14
Score0/3
Weight12.88%
1M Return-7.31%
Value0.14
Score0/3
Weight12.88%
1M Return-7.31%
EBIT / Total operating revenue (%)
Value-2086.32
Score0/3
Weight15.63%
1M Return-7.44%
Value-2086.32
Score0/3
Weight15.63%
1M Return-7.44%
Asset-MV
Value-0.50
Score1/3
Weight1.57%
1M Return-0.51%
Value-0.50
Score1/3
Weight1.57%
1M Return-0.51%
Net profit / Total operating revenue (%)
Value-2126.62
Score0/3
Weight16.21%
1M Return-7.85%
Value-2126.62
Score0/3
Weight16.21%
1M Return-7.85%
Is COEP undervalued or overvalued?
- COEP scores 0.78/10 on fundamentals and holds a Premium valuation at present. Backed by its -139.87% ROE, 0.00% net margin, -5.24 P/E ratio, 5.95 P/B ratio, and -417.83% earnings growth, these metrics solidify its Underperform investment rating.
